SE9402531L - Sårläkningsmedel - Google Patents

Sårläkningsmedel

Info

Publication number
SE9402531L
SE9402531L SE9402531A SE9402531A SE9402531L SE 9402531 L SE9402531 L SE 9402531L SE 9402531 A SE9402531 A SE 9402531A SE 9402531 A SE9402531 A SE 9402531A SE 9402531 L SE9402531 L SE 9402531L
Authority
SE
Sweden
Prior art keywords
pct
chitosan
polysaccharide
composition
wound healing
Prior art date
Application number
SE9402531A
Other languages
English (en)
Swedish (sv)
Other versions
SE9402531D0 (sv
Inventor
Olle Larm
Ibrahim Gouda
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Priority to SE9402531A priority Critical patent/SE9402531L/xx
Publication of SE9402531D0 publication Critical patent/SE9402531D0/xx
Priority to DK95926574T priority patent/DK0759760T3/da
Priority to US08/765,353 priority patent/US5902798A/en
Priority to PCT/SE1995/000875 priority patent/WO1996002260A1/en
Priority to AU30902/95A priority patent/AU691322B2/en
Priority to AT95926574T priority patent/ATE207753T1/de
Priority to JP50496696A priority patent/JP3337472B2/ja
Priority to CA002194976A priority patent/CA2194976C/en
Priority to ES95926574T priority patent/ES2161903T3/es
Priority to EP95926574A priority patent/EP0759760B1/de
Priority to DE69523585T priority patent/DE69523585T2/de
Publication of SE9402531L publication Critical patent/SE9402531L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Surgical Instruments (AREA)
SE9402531A 1994-07-19 1994-07-19 Sårläkningsmedel SE9402531L (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel
DE69523585T DE69523585T2 (de) 1994-07-19 1995-07-18 Wundheilmittel
AU30902/95A AU691322B2 (en) 1994-07-19 1995-07-18 Wound healing agent
US08/765,353 US5902798A (en) 1994-07-19 1995-07-18 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate
PCT/SE1995/000875 WO1996002260A1 (en) 1994-07-19 1995-07-18 Wound healing agent
DK95926574T DK0759760T3 (da) 1994-07-19 1995-07-18 Sårhelingsmiddel
AT95926574T ATE207753T1 (de) 1994-07-19 1995-07-18 Wundheilmittel
JP50496696A JP3337472B2 (ja) 1994-07-19 1995-07-18 創傷治癒剤
CA002194976A CA2194976C (en) 1994-07-19 1995-07-18 Wound healing agent
ES95926574T ES2161903T3 (es) 1994-07-19 1995-07-18 Agente para curar heridas.
EP95926574A EP0759760B1 (de) 1994-07-19 1995-07-18 Wundheilmittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel

Publications (2)

Publication Number Publication Date
SE9402531D0 SE9402531D0 (sv) 1994-07-19
SE9402531L true SE9402531L (sv) 1996-01-20

Family

ID=20394771

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel

Country Status (11)

Country Link
US (1) US5902798A (de)
EP (1) EP0759760B1 (de)
JP (1) JP3337472B2 (de)
AT (1) ATE207753T1 (de)
AU (1) AU691322B2 (de)
CA (1) CA2194976C (de)
DE (1) DE69523585T2 (de)
DK (1) DK0759760T3 (de)
ES (1) ES2161903T3 (de)
SE (1) SE9402531L (de)
WO (1) WO1996002260A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576839A (en) * 1991-09-25 1996-11-19 Minolta Camera Kabushiki Kaisha Camera system including a separatable recorder
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6391334B1 (en) 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
AU1848601A (en) * 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
GB9929472D0 (en) * 1999-12-13 2000-02-09 Btg Int Ltd Polymeric film
US20020082220A1 (en) * 2000-06-29 2002-06-27 Hoemann Caroline D. Composition and method for the repair and regeneration of cartilage and other tissues
DE60125973D1 (de) * 2000-11-15 2007-02-22 Biosyntech Canada Inc Verfahren zur wiederherstellung einer geschädigten bandscheibe
US6623761B2 (en) 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
KR20020066024A (ko) * 2001-02-08 2002-08-14 굿젠 주식회사 수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
US7153492B2 (en) 2001-04-12 2006-12-26 Medicarb Ab Effervescent solid composition of matter
SE522529C2 (sv) 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
KR20020060627A (ko) * 2002-01-16 2002-07-18 조석형 키토산/음이온성 다당류의 창상 치유제
AU2003215280A1 (en) 2002-02-15 2003-09-09 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
CA2493083C (en) * 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
JP2006347883A (ja) * 2003-09-08 2006-12-28 Neetec:Kk 糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物
ATE541580T1 (de) 2003-12-05 2012-02-15 Univ Northwestern Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
CA2598251A1 (en) * 2005-03-04 2006-09-14 Northwestern University Angiogenic heparin binding peptide amphiphiles
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
EP1958613A1 (de) * 2007-02-15 2008-08-20 Polichem S.A. Dermale filmbildende flüssige Formulierungen zur Wirkstofffreisetzung auf der Haut
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
DK2195039T3 (en) 2007-08-28 2017-01-30 Otago Innovation Ltd SURGICAL HYDROGEL
US9440099B2 (en) * 2008-11-20 2016-09-13 Laboratori Derivati Organici Spa Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
RU2519225C2 (ru) * 2008-12-06 2014-06-10 Б. Браун Мельзунген Аг Опосредующие транспорт коллоидные лекарственные соединения
US9018372B2 (en) 2009-03-31 2015-04-28 B. Braun Melsungen Ag Bonding products of aminated polysaccharides
WO2010120830A1 (en) 2009-04-13 2010-10-21 Northwestern University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
US8906883B2 (en) * 2009-06-10 2014-12-09 Exthera Ab Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
EP2473201B1 (de) 2009-09-01 2016-08-10 Medovent GmbH Gewebeauflage aus chitosan
KR20130018739A (ko) 2010-03-03 2013-02-25 네오큐티스 에스아 항균 펩티드 격리 화합물을 사용한 피부 질환 및 장애의 치료를 위한 조성물 및 방법
CN105451745B (zh) 2013-08-13 2018-03-27 生化学工业株式会社 含有阳离子化壳聚糖的药物
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
US10126298B2 (en) 2015-05-04 2018-11-13 Arman Nabatian Hydrogels containing embedded substrates for targeted binding of molecules
US9248160B1 (en) * 2015-07-28 2016-02-02 Zo Skin Health, Inc. Post-procedure skin care systems, compositions, and methods of use thereof
KR102712081B1 (ko) * 2018-01-12 2024-10-02 보스톤 싸이엔티픽 싸이메드 인코포레이티드 지혈을 달성하기 위한 분말
EP3787593A1 (de) 2018-05-04 2021-03-10 Bonoss Medical Aktiebolag Zusammensetzung zur verminderung der narbenbildung
FR3150119B1 (fr) * 2023-06-20 2026-03-13 Oreal Composition à base de chitosan et d’un polysaccharide modifié

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378017A (en) * 1980-03-21 1983-03-29 Kureha Kagaku Kogyo Kabushiki Kaisha Composite material of de-N-acetylated chitin and fibrous collagen
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
JP3205104B2 (ja) * 1992-01-20 2001-09-04 川研ファインケミカル株式会社 化粧料
SE9402529D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel

Also Published As

Publication number Publication date
DK0759760T3 (da) 2001-11-26
AU3090295A (en) 1996-02-16
ATE207753T1 (de) 2001-11-15
CA2194976A1 (en) 1996-02-01
JPH10502665A (ja) 1998-03-10
US5902798A (en) 1999-05-11
JP3337472B2 (ja) 2002-10-21
EP0759760A1 (de) 1997-03-05
DE69523585D1 (de) 2001-12-06
EP0759760B1 (de) 2001-10-31
AU691322B2 (en) 1998-05-14
ES2161903T3 (es) 2001-12-16
WO1996002260A1 (en) 1996-02-01
CA2194976C (en) 2002-04-30
DE69523585T2 (de) 2002-04-11
SE9402531D0 (sv) 1994-07-19

Similar Documents

Publication Publication Date Title
SE9402531D0 (sv) Sårläkningsmedel
US5929050A (en) Chondroitin sulfate composition and method for wound treatment
KR970704459A (ko) 경조직 자극제(Hard Tissue Stimulating Agent)
NO20035569D0 (no) Sårbandasje og metode for kontroll av livstruende bl degree dning
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
EP0815144A4 (de) Verfahren zur herstellung von glucan und therapeutische verwendung von glucan
BR0304601A (pt) Curativo de ferimento hemostático contendo polissacarìdeos modificados por aldeìdo
DE69702911D1 (de) Oxydierte oligosaccharide
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
NZ290218A (en) Composition to reduce adhesion in wound healing
RU97102350A (ru) Анти-адгезионный агент
BR9401241A (pt) Composição aquosa para tratamento de feridas e processo para formar a mesma
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
PT1017403E (pt) Utilizacao de hialuronato de zinco contra a ulcera peptica
DK0917427T3 (da) Pattedypningsmiddel
ATE201823T1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
BR9407669A (pt) Bandagem de ferida que compreende alginato
SE9303612D0 (sv) New use
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69900648D1 (de) Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
EA199800819A1 (ru) Способ лечения биполярного расстройства
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung

Legal Events

Date Code Title Description
NAV Patent application has lapsed